COVID-19 vaccine developed by AstraZeneca and the University of Oxford has been put on hold over a “potentially unexplained illness” in the United Kingdom, according to media reports.Oxford University has partnered with AstraZeneca, a British-Swedish multinational pharmaceutical and biopharmaceutical company, to produce 2 billion doses of the vaccine.
Here’s when experts say Oxford University’s coronavirus vaccine could be ready Stat News was the first to report the development.In a statement emailed to Stat News, CNN and CNBC, a spokesperson from AstraZeneca said the company’s “standard review process triggered a pause to vaccination to allow review of safety data.”“This is a routine action which has to happen whenever there is a.